Sunday, September 30, 2018

Mankind Pharma eyes $1 billion topline by FY21

Mankind Pharma eyes $1 billion topline by FY21 The company is also looking at increasing its exports substantially to $100-150 million in the next three years from the present $10 million.

from Moneycontrol Business News https://ift.tt/2Qla994

No comments:

Post a Comment

Tariffs a temporary storm, structural reforms key for India: Arvind Sanger

Arvind Sanger of Geosphere Capital Management suggests a trade deal with the U.S. would benefit India by reducing market uncertainty and pro...